| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8945187 | Gynecologic Oncology | 2018 | 6 Pages |
Abstract
ARID1A immunostaining may correlate with malignant transformation and the presence of concurrent EEC in patients with CAH identified at pre-hysterectomy endometrial sampling. Further investigation to determine the potential utility of ARID1A expression as a tissue biomarker is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ting-Tai Yen, Tsutomu Miyamoto, Shiho Asaka, M. Herman Chui, Yeh Wang, Shiou-Fu Lin, Rebecca L. Stone, Amanda N. Fader, Ryoichi Asaka, Hiroyasu Kashima, Tanri Shiozawa, Tian-Li Wang, Ie-Ming Shih, Edward J. III,